ArticleJournal of clinical medicine2024

Effects of Vildagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on the Parameters of Glucose Metabolism and the Cardio-Ankle Vascular Index in Individuals with Type 2 Diabetes.

Daiji Nagayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.